Drusen Volume and Retinal Pigment Epithelium Abnormal Thinning Volume Predict 2-Year Progression of Age-Related Macular Degeneration

Ophthalmology

Volumn 123, Issue 1, 2016, Pages 39-50.e1

  Folgar, Francisco A ^a   Yuan, Eric L ^a   Sevilla, Monica B ^a   Chiu, Stephanie J ^a,b   Farsiu, Sina ^a,b   Chew, Emily Y ^c   Toth, Cynthia A ^a,b  

^a DUKE UNIVERSITY EYE CENTER   (United States)

^b Duke University   (United States)

^c NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE RELATED MACULAR DEGENERATION; AGED; COHORT ANALYSIS; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; FUNDUS CAMERA; GEOGRAPHIC ATROPHY; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINAL PIGMENT EPITHELIUM DRUSEN ABNORMAL THINNING VOLUME; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBRETINAL NEOVASCULARIZATION; VISUAL SYSTEM PARAMETERS; CLINICAL TRIAL; COMPLICATION; FEMALE; MACULAR DEGENERATION; MALE; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PROGNOSIS; RETINAL DRUSEN; RETINAL PIGMENT EPITHELIUM; TIME FACTOR;

AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACULAR DEGENERATION; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RETINAL DRUSEN; RETINAL PIGMENT EPITHELIUM; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84951905009     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2015.09.016     Document Type: Conference Paper

References (36)

1. Abdelsalam A, Del Priore L, Zarbin MA. Drusen in agerelated macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. Surv Ophthalmol 1999;44:1-29.
2. Zweifel SA, Imamura Y, Spaide TC, et al. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology 2010;117:1775-81.
3. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1997;104:7-21.
4. Age Related Eye Disease Study Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study report number 6. Am J Ophthalmol 2001;132:668-81.
5. Ferris FL 3rd, Wilkinson CP, Bird A, et al. Clinical classification of age-related macular degeneration. Ophthalmology 2013;120:844-51.
6. Age Related Eye Disease Study Group. The Age-Related Eye Disease Study severity scale for age-relatedmacular degeneration: AREDS report no. 17. Arch Ophthalmol 2005;123:1484-98.
7. Age Related Eye Disease Study Group. A simplified severity scale for age-related macular degeneration: AREDS report no. 18. Arch Ophthalmol 2005;123:1570-4.
8. Macular Photocoagulation Study Group. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 1997;115:741-7.
9. Ying GS, Maguire MG, Alexander J, et al; Complications of Age-related Macular Degeneration Prevention Trial Research Group. Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-Related Macular Degeneration Prevention Trial. Arch Ophthalmol 2009;127:1147-51.
10. Stopa M, Bower BA, Davies E, et al. Correlation of pathologic features in spectral domain optical coherence tomography with conventional retinal studies. Retina 2008;28: 298-308.
11. Khanifar AA, Koreishi AF, Izatt JA, Toth CA. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology 2008;115:1883-90.
12. Schuman SG, Koreishi AF, Farsiu S, et al. Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. Ophthalmology 2009;116:488-96.
13. Jain N, Farsiu S, Khanifar AA, et al. Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs. Invest Ophthalmol Vis Sci 2010;51: 4875-83.
14. Chiu SJ, Li XT, Nicholas P, et al. Automatic segmentation of seven retinal layers in SDOCT images congruent with expert manual segmentation. Opt Express 2010;18:19413-28.
15. Chiu SJ, Izatt JA, O'Connell RV, et al. Validated automatic segmentation of AMD pathology including drusen and geographic atrophy in SD-OCT Images. Inv Ophthalmol Vis Sci 2012;53:53-61.
16. Farsiu S, Chiu SJ, O'Connell RV, et al. Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography. Ophthalmology 2014;121:162-72.
17. Age-Related Eye Disease Study 2 Research Group. Lutein \+ zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013;309: 2005-15.
18. Leuschen JN, Schuman SG, Winter KP, et al. Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration. Ophthalmology 2013;120: 140-50.
19. Folgar FA, Chow JH, Farsiu S, et al. Spatial correlation between hyperpigmentary changes on color fundus photography and hyperreflective foci on SDOCT in intermediate AMD. Invest Ophthalmol Vis Sci 2012;53:4626-33.
20. Christenbury JG, Folgar FA, O'Connell RV, et al. Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci. Ophthalmology 2013;120:1038-45.
21. Danis RP, Domalpally A, Chew EY, et al. Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 report number 2). Invest Ophthalmol Vis Sci 2013;54:4548-54.
22. Yi K, Mujat M, Park BH, et al. Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular agerelated macular degeneration. Br J Ophthalmol 2009;93: 176-81.
23. Gregori G, Wang F, Rosenfeld PJ, et al. Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration. Ophthalmology 2011;118:1373-9.
24. Yehoshua Z, Wang F, Rosenfeld PJ, et al. Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. Ophthalmology 2011;118:2434-41.
25. de Sisternes L, Simon N, Tibshirani R, et al. Quantitative SDOCT imaging biomarkers as indicators of age-related macular degeneration progression. Invest Ophthalmol Vis Sci 2014;55: 7093-103.
26. Garcia Filho CA, Yehoshua Z, Gregori G, et al. Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina 2014;45: 18-31.
27. Sarks SH, Arnold JJ, Killingsworth MC, Sarks JP. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. Br J Ophthalmol 1999;83:358-68.
28. Nittala MG, Ruiz-Garcia H, Sadda SR. Accuracy and reproducibility of automated drusen segmentation in eyes with nonneovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2012;53:8319-24.
29. Chen Q, Leng T, Zheng L, et al. Automated drusen segmentation and quantification in SD-OCT images. Med Image Anal 2013;17:1058-72.
30. Lee JY, Chiu SJ, Srinivasan PP, et al. Fully automatic software for retinal thickness in eyes with diabetic macular edema from images acquired by cirrus and spectralis systems. Invest Ophthalmol Vis Sci 2013;54:7595-602.
31. Folgar FA, Yuan EL, Farsiu S, Toth CA. Lateral and axial measurement differences between spectral-domain optical coherence tomography systems. J Biomed Opt 2014;19: 16014.
32. Yehoshua Z, Rosenfeld PJ, Gregori G, et al. Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography. Ophthalmology 2011;118:679-86.
33. Fleckenstein M, Schmitz-Valckenberg S, Adrion C, et al. Tracking progression with spectral-domain optical coherence tomography in geographic atrophy caused by age-related macular degeneration. Invest Ophthalmol Vis Sci 2010;51: 3846-52.
34. Schutze C, Ahlers C, Sacu S, et al. Performance of OCT segmentation procedures to assess morphology and extension in geographic atrophy. Acta Ophthalmol 2011;89:235-40.
35. Chen Q, de Sisternes L, Leng T, et al. Semi-automatic geographic atrophy segmentation for SD-OCT images. Biomed Opt Express 2013;4:2729-50.
36. Diniz B, Rodger DC, Chavali V, et al. Drusen and RPE atrophy automated quantification by optical coherence tomography in an elderly population. Eye 2015;29:272-9.